Français
ItalianoBond Bristol Myers Squibb 2% ( US110122AT56 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||||||||
| Market price | 99.92 % ▼ | ||||||||||||||
| Country |  United States
|
||||||||||||||
| ISIN code |
 US110122AT56 ( in USD )
|
||||||||||||||
| Interest rate | 2% per year ( payment 2 times a year) | ||||||||||||||
| Maturity | 01/08/2022 - Bond has expired | ||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||
| Minimal amount | / | ||||||||||||||
| Total amount | / | ||||||||||||||
| Cusip | 110122AT5 | ||||||||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US110122AT56 (CUSIP: 110122AT5) 2% USD-denominated bond, maturing on 01/08/2022, has reached maturity and been redeemed at a price of 99.922%. |
||||||||||||||
| |||||||||||||||